CAMDEN NATIONAL CORP Income Taxes Disclosure
| For the Year Ended December 31, | ||||||||||||||||||||
| (In thousands) | 2025 | 2024 | 2023 | |||||||||||||||||
| Current: | ||||||||||||||||||||
| Federal | $ | 10,779 | $ | 11,047 | $ | 7,990 | ||||||||||||||
| State | 2,100 | 1,111 | 1,156 | |||||||||||||||||
| Total | 12,879 | 12,158 | 9,146 | |||||||||||||||||
| Deferred: | ||||||||||||||||||||
| Federal | 3,346 | 291 | 1,277 | |||||||||||||||||
| State | (2,730) | 7 | 30 | |||||||||||||||||
| Total | 616 | 298 | 1,307 | |||||||||||||||||
| Income tax expense | $ | 13,495 | $ | 12,456 | $ | 10,453 | ||||||||||||||
| For the Year Ended December 31, | ||||||||
| (In thousands) | 2025 | |||||||
| Federal | $ | 4,600 | ||||||
Maine | 950 | |||||||
New Hampshire | 303 | |||||||
Other states | 301 | |||||||
| Total | $ | 6,154 | ||||||
For the Year Ended December 31, 2025 | ||||||||||||||
| (Dollars in thousands) | Amount | Rate | ||||||||||||
Income before income tax expense (domestic) | $ | 78,655 | ||||||||||||
Tax at U.S. statutory rate | $ | 16,518 | 21.0 | % | ||||||||||
State taxes, net of federal benefit(1)(2) | (498) | (0.1) | % | |||||||||||
Tax credit benefits | (668) | (0.8) | % | |||||||||||
Nontaxable and nondeductible items: | ||||||||||||||
Tax exempt income | (1,111) | (1.4) | % | |||||||||||
| Income from life insurance | (722) | (0.9) | % | |||||||||||
| Share-based awards | (44) | (0.1) | % | |||||||||||
Merger and acquisition costs | 28 | — | % | |||||||||||
| Other | (8) | — | % | |||||||||||
Income tax expense | $ | 13,495 | 17.2 | % | ||||||||||
| For the Year Ended December 31, | ||||||||||||||
| (Dollars in thousands) | 2024 | 2023 | ||||||||||||
| Computed tax expense | $ | 13,747 | $ | 11,306 | ||||||||||
| Increase (reduction) in income taxes resulting from: | ||||||||||||||
Tax credit benefits | (1,699) | (831) | ||||||||||||
| State taxes, net of federal benefit | 1,099 | 937 | ||||||||||||
| Income from life insurance | (589) | (493) | ||||||||||||
| Tax exempt income | (451) | (647) | ||||||||||||
Merger and acquisition costs | 232 | — | ||||||||||||
| Share-based awards | 98 | 69 | ||||||||||||
| Other | 19 | 112 | ||||||||||||
| Income tax expense | $ | 12,456 | $ | 10,453 | ||||||||||
| Income before income tax expense | $ | 65,460 | $ | 53,836 | ||||||||||
| Effective tax rate | 19.0 | % | 19.4 | % | ||||||||||
| December 31, | ||||||||||||||||||||||||||
2025(1) | 2024(2) | |||||||||||||||||||||||||
| (In thousands) | Asset | Liability | Asset | Liability | ||||||||||||||||||||||
Purchase accounting | $ | 23,580 | $ | — | $ | — | $ | (1,135) | ||||||||||||||||||
| Net unrealized losses on AFS debt securities | 20,260 | — | 28,488 | — | ||||||||||||||||||||||
| Allowance for credit losses | 11,021 | — | 8,285 | — | ||||||||||||||||||||||
| Net operating loss and tax credit carryforward | 5,753 | — | 6,255 | — | ||||||||||||||||||||||
| Pension and other benefits | 5,344 | — | 4,319 | — | ||||||||||||||||||||||
| Deferred compensation and benefits | 1,351 | — | 1,161 | — | ||||||||||||||||||||||
CDI assets | — | (9,576) | 103 | |||||||||||||||||||||||
| Deferred loan origination fees | — | (3,346) | — | (3,152) | ||||||||||||||||||||||
| Depreciation | — | (3,092) | — | (2,352) | ||||||||||||||||||||||
Net unrealized gains on derivative instruments | — | (1,550) | — | (2,454) | ||||||||||||||||||||||
| Other | 1,334 | — | 519 | — | ||||||||||||||||||||||
| Gross deferred tax assets (liabilities) | $ | 68,643 | (17,564) | $ | 49,130 | (9,093) | ||||||||||||||||||||
| Valuation allowance on deferred tax assets | — | — | ||||||||||||||||||||||||
| Net deferred tax assets | $ | 51,079 | $ | 40,037 | ||||||||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 6, 2026 | Showing above |
| 2024 | Mar 7, 2025 | |
| 2023 | Mar 8, 2024 | |
| 2022 | Mar 10, 2023 | |
| 2021 | Mar 11, 2022 | |
| 2020 | Mar 15, 2021 | |
| 2019 | Mar 11, 2020 | |
| 2018 | Mar 13, 2019 | |
| 2017 | Mar 9, 2018 | |
| 2016 | Mar 7, 2017 | |
| 2015 | Mar 11, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.